S511-0501 Screening compound: N-cyclopropyl-2-[9-(3-ethoxybenzyl)-1-oxa-9-azaspiro[5.5]undec-4-yl]acetamide

S511-0501 Screening compound: N-cyclopropyl-2-[9-(3-ethoxybenzyl)-1-oxa-9-azaspiro[5.5]undec-4-yl]acetamide
S511-0501 Screening compound: N-cyclopropyl-2-[9-(3-ethoxybenzyl)-1-oxa-9-azaspiro[5.5]undec-4-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S511-0501
N-cyclopropyl-2-[9-(3-ethoxybenzyl)-1-oxa-9-azaspiro[5.5]undec-4-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S511-0501

Molecular Formula

C23H34N2O3 (C23 H34 N2 O3)

Compound Name

N-cyclopropyl-2-[9-(3-ethoxybenzyl)-1-oxa-9-azaspiro[5.5]undec-4-yl]acetamide

IUPAC name

N-cyclopropyl-2-{9-[(3-ethoxyphenyl)methyl]-1-oxa-9-azaspiro[5.5]undecan-4-yl}acetamide

SMILES

CCOc1cccc(CN(CC2)CCC22OCCC(CC(NC3CC3)=O)C2)c1

InChI

InChI=1S/C23H34N2O3/c1-2-27-21-5-3-4-19(14-21)17-25-11-9-23(10-12-25)16-18(8-13-28-23)15-22(26)24-20-6-7-20/h3-5,14,18,20H,2,6-13,15-17H2,1H3,(H,24,26)/t18-/m1/s1

InChI Key

BJCIIUFYXUEQEL-GOSISDBHSA-N

MDL Number (MFCD)

MFCD29018071

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

386.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.394

Distribution Coefficient, logD

1.104

Water Solubility, LogSw

-3.62

Polar Surface Area

41.953

Acid Dissociation Constant (pKa)

13.46

Base Dissociation Constant (pKb)

9.69

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

69.57

S511-0501 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • GPCR
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S511-0501 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S511-0501?
Check Price and Availability of S511-0501, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S511-0501 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S511-0501
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S511-0501
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S511-0501 available by request